Thespians and Bioterror

Frontlines | Thespians and Bioterror Courtesy of University of Louisville Healthcare workers face a reality problem in the face of bioterror: How do they prepare for possible epidemics, the signs and symptoms of which few have witnessed? The realistic answer: With a little touch of makeup magic. In its patient program, the University of Louisville employs a cosmetics specialist who simulates injury and converts actors into victims. They stage bioterrorism-related afflictions as real as fake

Written byEugene Russo
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Healthcare workers face a reality problem in the face of bioterror: How do they prepare for possible epidemics, the signs and symptoms of which few have witnessed? The realistic answer: With a little touch of makeup magic. In its patient program, the University of Louisville employs a cosmetics specialist who simulates injury and converts actors into victims. They stage bioterrorism-related afflictions as real as fake can be. Using actors to present symptoms to physicians-in-training is not unusual. But this is the first time it has been done in regard to bioterrorism.

"We can talk until we're blue in the face and describe something," says Gina Wesley, director of the medical school's standardized patient program. "But it's not until you actually see something, touch something, that you get a real grasp for how to spot it."

The Louisville experts, who have helped train state public health department workers to distinguish normal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies